Increasing LPP1 expression in syngeneic and xenograft breast and thyroid cancer models decreased tumor growth and metastasis by up to 80% through both increasing extracellular LPA degradation and decreasing the stimulation of Ca2+-transients by LPA [167]. The gene discussed is PLPP1; the disease is neoplasm.